(Q41673482)

6 October 2017

1 reference

title

Th1/Th2 cytokine balance in arthritis (English)

1 reference

6 October 2017

P. Miossec

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9416846

30 November 2024

W. van den Berg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9416846

30 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9416846

30 November 2024

publication date

1 December 1997

1 reference

6 October 2017

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9416846

full work available at URL

30 November 2024

https://repository.ubn.ru.nl/bitstream/2066/24983/1/24983.PDF

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9416846

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002/art.1780401203

30 November 2024

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.1780401203

30 November 2024

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

30 November 2024

published in

Arthritis & Rheumatology

1 reference

6 October 2017

Arthritis and Rheumatism

40

12

2105–15

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9416846

30 November 2024

volume

40

1 reference

6 October 2017

issue

12

1 reference

6 October 2017

page(s)

2105-2115

1 reference

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

6 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

30 November 2024

2

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

How important are T cells in chronic rheumatoid synovitis?

30 November 2024

3

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

30 November 2024

4

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives

30 November 2024

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Functional diversity of helper T lymphocytes

30 November 2024

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Bypassing the antigen to control rheumatoid arthritis

30 November 2024

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Diversity of cytokine synthesis and function of mouse CD4 T cells

30 November 2024

11

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Human TH1 and TH2 subsets: doubt no more

30 November 2024

12

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

30 November 2024

13

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset

30 November 2024

14

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns

30 November 2024

15

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

30 November 2024

17

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Different cytokine production profiles of gamma delta T cell clones: relation to inflammatory arthritis

30 November 2024

18

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Differential effects of interleukins 10 and 4 on the production of interleukin‐6 by blood and synovium monocytes in rheumatoid arthritis

30 November 2024

19

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium

30 November 2024

20

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10

30 November 2024

21

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis

30 November 2024

22

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor

30 November 2024

23

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

30 November 2024

25

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function

30 November 2024

26

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interferon gamma inhibits interleukin 10 production by monocytes

30 November 2024

27

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

30 November 2024

29

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

30 November 2024

30

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

An interleukin-4-induced transcription factor: IL-4 Stat

30 November 2024

31

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Essential role of Stat6 in IL-4 signalling

30 November 2024

32

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Enrichment of differentiated CD45RBdim,CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis

30 November 2024

34

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

30 November 2024

35

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Role of B7 signaling in the differentiation of naive CD4 T cells to effector interleukin-4-producing T helper cells

30 November 2024

36

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

CD28/B7 system of T cell costimulation

30 November 2024

37

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

30 November 2024

39

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

30 November 2024

42

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interleukin 2 (IL 2) inhibitor in rheumatoid synovial fluid: correlation with prognosis and soluble IL 2 receptor levels

30 November 2024

43

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Restricted cytokine expression in rheumatoid arthritis

30 November 2024

44

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis

30 November 2024

45

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

30 November 2024

46

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis

30 November 2024

47

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

30 November 2024

48

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Selection of a human T helper type 1-like T cell subset by mycobacteria

30 November 2024

49

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

30 November 2024

50

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Organ-specific disease provoked by systemic autoimmunity

30 November 2024

51

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues

30 November 2024

52

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

30 November 2024

53

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells?

30 November 2024

54

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4

30 November 2024

56

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis

30 November 2024

58

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

30 November 2024

59

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10

30 November 2024

60

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interleukin-10-deficient mice develop chronic enterocolitis

30 November 2024

61

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

30 November 2024

62

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

30 November 2024

63

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation

30 November 2024

65

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice

30 November 2024

66

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis

30 November 2024

68

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

30 November 2024

70

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4 T cells

30 November 2024

71

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

30 November 2024

72

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

30 November 2024

74

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

30 November 2024

75

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis

30 November 2024

78

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4

30 November 2024

79

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes

30 November 2024

80

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes

30 November 2024

81

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

30 November 2024

82

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

30 November 2024

83

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases.

30 November 2024

84

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

30 November 2024

85

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis

30 November 2024

86

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Sustained remission of rheumatoid arthritis following hypersensitivity reaction

30 November 2024

87

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome

30 November 2024

88

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases?

30 November 2024

89

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Effects of oral administration of type II collagen on rheumatoid arthritis

30 November 2024

91

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial

30 November 2024

92

1 reference

https://api.crossref.org/works/10.1002/ART.1780401203

30 November 2024

Identifiers

1 reference

6 October 2017

1 reference